Clinical Trial Update: Norepinephrine Transporter Availability in PTSD [Phase 1]

View source ↗

Summary

Phase 1 study conducted by Emory University assessing norepinephrine transporter availability in individuals with posttraumatic stress disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Snippet

Sponsor: Emory University | Conditions: Posttraumatic Stress Disorder | Phase 1 | Status: COMPLETED